Longterm results of liver transplantation from donation after circulatory death

Liver Transplantation

Volumn 22, Issue 8, 2016, Pages 1107-1114

  Blok, Joris J ^a   Detry, Olivier ^b   Putter, Hein ^a   Rogiers, Xavier ^c   Porte, Robert J ^d   van Hoek, Bart ^a   Pirenne, Jacques ^e   Metselaar, Herold J ^f   Lerut, Jan P ^g   Ysebaert, Dirk K ^h   Lucidi, Valerio ⁱ   Troisi, Roberto I ^c   Samuel, Undine ^j   den Dulk, A Claire ^a   Ringers, Jan ^a   Braat, Andries E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

ⁱ ERASME HOSPITAL   (Belgium)

^j EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BELGIUM; CADAVER DONOR; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; ISCHEMIA; KAPLAN MEIER METHOD; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NETHERLANDS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETRANSPLANTATION; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; UNIVARIATE ANALYSIS;

EID: 84979582484     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24449     Document Type: Article

References (31)

1. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783–790.
2. Braat AE, Blok JJ, Putter H, Adam R, Burroughs AK, Rahmel AO, et al.; for European Liver and Intestine Transplant Association (ELITA) and Eurotransplant Liver Intestine Advisory Committee (ELIAC). The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant 2012;12:2789–2796.
3. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004;239:87–92.
4. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 2005;242:724–731.
5. Fung JJ, Eghtesad B, Patel-Tom K. Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl 2007;13:1633–1636.
6. Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, et al. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index. Am J Transplant 2014;14:2588–2594.
7. Dubbeld J, Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010;97:744–753.
8. Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol 2011;55:808–813.
9. Tariciotti L, Rocha C, Perera MT, Gunson BK, Bramhall SR, Isaac J, et al. Is it time to extend liver acceptance criteria for controlled donors after cardiac death? Transplantation 2011;92:1140–1146.
10. Detry O, Donckier V, Lucidi V, Ysebaert D, Chapelle T, Lerut J, et al. Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007. Transpl Int 2010;23:611–618.
11. Meurisse N, Vanden Bussche S, Jochmans I, Francois J, Desschans B, Laleman W, et al. Outcomes of liver transplantations using donations after circulatory death: a single-center experience. Transplant Proc 2012;44:2868–2873.
12. Detry O, Deroover A, Meurisse N, Hans MF, Delwaide J, Lauwick S, et al. Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme. Br J Surg 2014;101:784–792.
13. Dubbeld J, van Hoek B, Ringers J, Metselaar H, Kazemier G, van den Berg A, Porte RJ. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcome from a single center. Ann Surg 2015;261:e64.
14. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant 2010;10:2512–2519.
15. Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, D'Alessandro A. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011;253:817–825.
16. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307–313.
17. Mateo R, Cho Y, Singh G, Stapfer M, Donovan J, Kahn J, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006;6:791–796.
18. Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? J Hepatol 2006;45:484–488.
19. Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl JL, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg 2011;253:259–264.
20. Singhal A, Wima K, Hoehn RS, Quillin RC 3rd, Woodle ES, Paquette IM, et al. Hospital resource use with donation after cardiac death allografts in liver transplantation: a matched controlled analysis from 2007 to 2011. J Am Coll Surg 2015;220:951–958.
21. van der Hilst CS, Ijtsma AJ, Bottema JT, van Hoek B, Dubbeld J, Metselaar HJ, et al. The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study. Transpl Int 2013;26:411–418.
22. Vekemans K, Monbaliu D, Balligand E, Heedfeld V, Jochmans I, Pirenne J, van Pelt J. Improving the function of liver grafts exposed to warm ischemia by the leuven drug protocol: exploring the molecular basis by microarray. Liver Transpl 2012;18:206–218.
23. Blok JJ, Braat AE, Ringers J. Reply to: asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transpl Int 2013;26:e15–e16.
24. Eurotransplant Manual. Definitions of ischemic time. Version 3.0. 2013. http://www.eurotransplant.org/cms/mediaobject.php?file=Chapter9_thedonor7.pdf.
25. Taner CB, Bulatao IG, Perry DK, Sibulesky L, Willingham DL, Kramer DJ, Nguyen JH. Asystole to cross-clamp period predicts development of biliary complications in liver transplantation using donation after cardiac death donors. Transpl Int 2012;25:838–846.
26. Burcin Taner C, Bulatao IG, Perry DK, Sibulesky L, Wllingham DL, Kramer DJ, Nguyen JH. Agonal period in donation after cardiac death donors. Transpl Int 2013;26:e17–e18.
27. Ringers J, Spreij A, Costeris N, Bokhorst AG, Braat AE, Drost G, et al. Modelprotocol postmortale orgaan- en weefseldonatie. Leiden, the Netherlands: Nerderlandse Transplantatie Stichting; 2013:1–136.
28. Rahmel AO, editor. Annual Report 2013. Eurotransplant International Foundation. Leiden, the Netherlands. 2014:1–158.
29. Andrews PA, Burnapp L, Manas D; for British Transplantation Society. Summary of the British Transplantation Society guidelines for transplantation from donors after deceased circulatory death. Transplantation 2014;97:265–270.
30. Monbaliu D, Pirenne J, Talbot D. Liver transplantation using donation after cardiac death donors. J Hepatol 2012;56:474–485.
31. Firl DJ, Hashimoto K, O'Rourke C, Diago-Uso T, Fujiki M, Aucejo FN, et al. Impact of donor age in liver transplantation from donation after circulatory death donors: a decade of experience at Cleveland Clinic. Liver Transpl 2015;21:1494–1503.